(57 days)
Not Found
No
The description focuses on standard digital radiography technology and image processing, with no mention of AI, ML, or related concepts.
No
Explanation: This device is for generating radiographic images and replacing film/screen systems in general-purpose diagnostic procedures. It is an imaging device for diagnosis, not a therapeutic device.
Yes
The "Intended Use / Indications for Use" section states that the device "is intended to replace radiographic film/screen systems in general-purpose diagnostic procedures."
No
The device description explicitly lists hardware components such as storage phosphor plates, plate carousels, and a scanner/digitizer as part of the system, in addition to the software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it is for "generating radiographic images of human anatomy" and "replace radiographic film/screen systems in general-purpose diagnostic procedures." This describes an imaging device used to visualize internal structures of the body, not a device used to examine specimens taken from the body (like blood, urine, or tissue).
- Device Description: The description details an X-ray imaging system that uses phosphor plates and a scanner to create digital images. This aligns with an in-vivo imaging system, not an in-vitro diagnostic device.
- Input Imaging Modality: The input modality is X-ray, which is used for imaging the body directly, not for analyzing samples.
- Anatomical Site: The anatomical site is "human anatomy," indicating it's used on the living body.
IVD devices are used to examine specimens outside of the body to provide information for diagnosis, monitoring, or treatment. This device operates by imaging the body directly.
N/A
Intended Use / Indications for Use
The CRystalView T-Series is indicated for use in generating radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in general-purpose diagnostic procedures. The CRystalView T-Series is not indicated for use in mammography.
Product codes
90-MQB
Device Description
The CRystal View T-Series System is an electrostatic X-ray imaging system that employs storage phosphor plates in place of conventional X-ray film for radiographic imaging applications. The system provides image data that must then be viewed with an external computer and appropriate software. The CRystal View T-Series System is comprised of the following functional components: Reusable storage phosphor plates, multiple sizes; Plate carousels, corresponding to reusable storage phosphor plate size; The CRystal View T-Series Scanner, an image reader /digitizer. The CRystal View T-Series Scanner / Communications Interface, USB 2.0; Optional Integrated phosphor plate eraser; CRystal View T-Series control software and a user or distribution channel-supplied computer system. Image data is sent via a dedicated connection from the CRystalView T-Series Scanner to the computer system, where it is processed and displayed for review.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray
Anatomical Site
human anatomy
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Alara's laboratory and V&V testing demonstrate that the CRystal View T-Series performance characteristics and diagnostic capabilities are equivalent to the predicate.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1680 Stationary x-ray system.
(a)
Identification. A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
KD71682
PREMARKET NOTIFICATION 510(k) CRystalView® T-Series Computed Radiography System
AUG 1 5 2007
E. 510(k) Summary Statement
CRystalView T-Series Computed Radiography System
This summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR 807.92.
| Submitter: | Alara, Inc.
47505 Seabridge Drive
Fremont, CA 94538 |
|----------------------|----------------------------------------------------------------------------------------------------------------------------|
| Registration Number: | 2953719 |
| Contact Person: | Robert Lundberg
Director of Regulatory Affairs and Quality Systems
Phone: 510-315-5189
Fax: 510-315-5201 |
| Date Prepared: | July 18, 2007 |
| Trade Name: | CRystalView® T-Series Computed Radiography System |
| Common Name: | Computed Radiography (CR) System |
| Classification Name: | Solid State X-Ray Imager
Class II, 21CFR 892.1650 |
| Product Code: | 90-MQB |
| Predicate Device: | K042023: Fuji Computed Radiography (FCR) ClearView CS
Image Reader (CR-IR363)
K955643; DenOptix ALARA Imaging System |
Product Description:
The CRystal View T-Series System is an electrostatic X-ray imaging system that employs storage phosphor plates in place of conventional X-ray film for radiographic imaging applications. The system provides image data that must then be viewed with an external computer and appropriate software. The CRystal View T-Series System is comprised of the following functional components: Reusable storage phosphor plates, multiple sizes; Plate carousels, corresponding to reusable storage phosphor plate size; The CRystal View T-Series Scanner, an image reader /digitizer. The CRystal View T-Series Scanner / Communications Interface, USB 2.0; Optional Integrated phosphor plate eraser;
1
Image /page/1/Picture/0 description: The image shows the text "A|L|A|R|A" in a bold, sans-serif font. The letters are separated by vertical lines. Below the letters, the word "INC" is written in a smaller font size. The text appears to be a logo or brand name.
CRystal View T-Series control software and a user or distribution channel-supplied computer system. Image data is sent via a dedicated connection from the CRystalView T-Series Scanner to the computer system, where it is processed and displayed for review.
Indications for Use:
The CRystalView T-Series is indicated for use in generating radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in generalpurpose diagnostic procedures.
The CRystal View T-Series is not indicated for use in mammography.
Rationale for Substantial Equivalence:
The CRystal View T-Series is the equivalent of the DenOptix Imaging System. Its "Intended Use" statement limits the DenOptix Imaging System to dental computed radiography. The Fuji Computed Radiography (FCR) ClearView CS Image Reader uses the same ST-VI Imaging Plates for general computed radiography that is the same "Intended Use" desired for the CRystalView T-Series. Differences between the FCR ClearView and the present device are in the implementation of similar technologies for computed radiography. These differences do not alter the intended diagnostic effect of a computed radiographic imaging system.
Safety and Effectiveness Information:
The CRystalView T-Series is a Class II medical device and a Class I laser product. The CRystalView T-Series complies with applicable FDA and international standards pertaining to electrical, mechanical, EMC, and laser safety of medical and/or laser devices.
Alara's laboratory and V&V testing demonstrate that the CRystal View T-Series performance characteristics and diagnostic capabilities are equivalent to the predicate.
Conclusion:
The CRystalView T-Series' performance is substantially equivalent to the DenOptix Imaging System and the FCR ClearView using the ST-VI imaging plates.
2
Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circle around the eagle. The logo is black and white.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Mr. Robert Lundberg Director, Regulatory Affairs & Quality Systems Alara, Inc. 47505 Seabridge Drive FREMONT CA 94538
AUG 2 3 2013
Re: K071682
Trade/Device Name: CRystalView® T-Series Computed Radiography System Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: II Product Code: MQB Dated: July 18, 2007 Received: July 20, 2007
Dear Mr. Lundberg:
This letter corrects our substantially equivalent letter of August 15, 2007.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
3
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 11 you don't the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours,
Janine M. Morris
Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
PREMARKET NOTIFICATION 510(k) CRystalView® T-Series Computed Radiography System
A|L|A|R|A®
INC.
C. Indications for Use Statement
| 510(k) Number: | K071682 |
|---|---|
| Device Name: | CRystalView ® T-Series Computed Radiography System |
| Indications for Use: | The CRystalView T-Series is indicated for use in generating radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in general-purpose diagnostic procedures. The CRystalView T-Series is not indicated for use in mammography. |
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) ーーー Concurrence of CDRH, Office of Device Evaluation (ODE)
D. Whang 8/15/07
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number